Oropeza-Almazán Yuriana, Vázquez-Garza Eduardo, Chapoy-Villanueva Héctor, Torre-Amione Guillermo, García-Rivas Gerardo
Cátedra de Cardiología y Medicina Vascular, Escuela de Medicina, Tecnológico de Monterrey, Monterrey, NL, Mexico.
Cátedra de Cardiología y Medicina Vascular, Escuela de Medicina, Tecnológico de Monterrey, Monterrey, NL, Mexico; Centro de Investigación Biomédica, Hospital Zambrano-Hellion, San Pedro Garza-García, NL, Mexico; Methodist DeBakey Heart and Vascular Center, The Methodist Hospital, Houston, TX, USA.
Oxid Med Cell Longev. 2017;2017:5750897. doi: 10.1155/2017/5750897. Epub 2017 Feb 27.
Intracellular Ca mishandling is an underlying mechanism in hypoxia/reoxygenation (H/R) injury that results in mitochondrial dysfunction and cardiomyocytes death. These events are mediated by mitochondrial Ca (Ca) overload that is facilitated by the mitochondrial calcium uniporter (MCU) channel. Along this line, we evaluated the effect of siRNA-targeting MCU in cardiomyocytes subjected to H/R injury. First, cardiomyocytes treated with siRNA demonstrated a reduction of MCU expression by 67%, which resulted in significant decrease in mitochondrial Ca transport. siRNA treated cardiomyocytes showed decreased mitochondrial permeability pore opening and oxidative stress trigger by Ca overload. Furthermore, after H/R injury MCU silencing decreased necrosis and apoptosis levels by 30% and 50%, respectively, and resulted in reduction in caspases 3/7, 9, and 8 activity. Our findings are consistent with previous conclusions that demonstrate that MCU activity is partly responsible for cellular injury induced by H/R and support the concept of utilizing siRNA-targeting MCU as a potential therapeutic strategy.
细胞内钙处理不当是缺氧/复氧(H/R)损伤的潜在机制,可导致线粒体功能障碍和心肌细胞死亡。这些事件由线粒体钙单向转运体(MCU)通道促进的线粒体钙(Ca)超载介导。据此,我们评估了靶向MCU的小干扰RNA(siRNA)对遭受H/R损伤的心肌细胞的影响。首先,用siRNA处理的心肌细胞显示MCU表达降低了67%,这导致线粒体钙转运显著减少。经siRNA处理的心肌细胞显示线粒体通透性转换孔开放减少以及由钙超载引发的氧化应激减少。此外,在H/R损伤后,MCU沉默分别使坏死和凋亡水平降低了30%和50%,并导致半胱天冬酶3/7、9和8活性降低。我们的研究结果与先前的结论一致,即表明MCU活性部分导致H/R诱导的细胞损伤,并支持将靶向MCU的siRNA用作潜在治疗策略的概念。